GeneNews Seeks to Raise $2.6M in Rights Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews announced after the close of the market on Wednesday a rights offering intended to raise about C$2.5 million (US$2.6 million).

Proceeds from the offering will go toward commercialization of the Toronto-based molecular diagnostics firm's ColonSentry test, a blood-based colon cancer risk stratification test, and for general corporate and administrative expenses, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.